Giorgia Guglielmi

Ketogenic diet may help treat autoimmune diseases by altering gut bacteria

The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…

Bacteria and other microbial signatures may predict immunotherapy success

The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.

“Super-donor” microbiota may restore gut health after fecal microbiota transplantation

By suggesting that the diversity and variety of microbial species play a big role in whether the transplanted microbes can successfully colonize a recipient’s gut, the findings could pave the…

Gut microbe linked to fat growth in Crohn’s disease

Targeting L-kynurenine metabolism could be a therapeutic strategy for managing Crohn’s disease.

New study challenges link between early-life gut microbiota and obesity risk

The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.

Small study uncovers gut microbiota differences in schizophrenia

New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.

Gut bacteria may improve response to immunotherapy in people with melanoma

Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.

New AI model predicts gut microbial load, revealing its role in health and disease

Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.

Tailored dietary strategies may boost remission for Crohn’s disease

The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top